NO20061502L - Fremgangsmate for behandling av endometriose - Google Patents

Fremgangsmate for behandling av endometriose

Info

Publication number
NO20061502L
NO20061502L NO20061502A NO20061502A NO20061502L NO 20061502 L NO20061502 L NO 20061502L NO 20061502 A NO20061502 A NO 20061502A NO 20061502 A NO20061502 A NO 20061502A NO 20061502 L NO20061502 L NO 20061502L
Authority
NO
Norway
Prior art keywords
endometriosis
nodules
procedure
treatment
administration
Prior art date
Application number
NO20061502A
Other languages
English (en)
Norwegian (no)
Inventor
Mirudhubashini Govindarajan
Original Assignee
Miscon Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miscon Trading Sa filed Critical Miscon Trading Sa
Publication of NO20061502L publication Critical patent/NO20061502L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Surgical Instruments (AREA)
NO20061502A 2003-09-03 2006-04-03 Fremgangsmate for behandling av endometriose NO20061502L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50021703P 2003-09-03 2003-09-03
US52635503P 2003-12-01 2003-12-01
PCT/IB2004/003103 WO2005020880A2 (en) 2003-09-03 2004-08-27 Methods for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
NO20061502L true NO20061502L (no) 2006-06-02

Family

ID=34278698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061502A NO20061502L (no) 2003-09-03 2006-04-03 Fremgangsmate for behandling av endometriose

Country Status (22)

Country Link
US (2) US9532995B2 (zh)
EP (2) EP2617411A1 (zh)
JP (2) JP5651279B2 (zh)
KR (2) KR101288265B1 (zh)
CN (1) CN101849906A (zh)
AU (1) AU2004267956B2 (zh)
BR (1) BRPI0413200A (zh)
CA (1) CA2537702C (zh)
DK (1) DK1660009T3 (zh)
EA (1) EA015356B1 (zh)
ES (1) ES2535430T3 (zh)
HK (1) HK1095529A1 (zh)
HR (1) HRP20150440T1 (zh)
HU (1) HUE025239T2 (zh)
IL (1) IL174014A0 (zh)
MA (1) MA28083A1 (zh)
NO (1) NO20061502L (zh)
PL (1) PL1660009T3 (zh)
PT (1) PT1660009E (zh)
SI (1) SI1660009T1 (zh)
TN (1) TNSN06070A1 (zh)
WO (1) WO2005020880A2 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
WO2009140126A1 (en) * 2008-05-14 2009-11-19 Juneau Biosciences, Llc Method of administering a therapeutic
EP2471537A1 (en) * 2010-12-30 2012-07-04 PregLem S.A. Treatment of pain associated with dislocation of basal endometrium
AR082266A1 (es) * 2011-05-13 2012-11-28 Univ Nac Del Litoral Microparticula inyectable de liberacion controlada
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20160287710A1 (en) * 2013-11-12 2016-10-06 Margit Maria JANAT-AMSBURY Glycol chitin based thermosensitive hydrogel for vaginal delivery of progesterone
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3174542A4 (en) 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
WO2018063985A1 (en) * 2016-09-28 2018-04-05 Atossa Genetics Inc. Methods of adoptive cell therapy
RU2661701C1 (ru) * 2017-02-09 2018-07-19 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Способ лапароскопического лечения узловых форм аденомиоза
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021173373A1 (en) * 2020-02-26 2021-09-02 Fordoz Pharma Corp. Injectable controlled-release formulations of progestogen drugs
RU2746476C1 (ru) * 2020-04-28 2021-04-14 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ хирургического лечения глубокого инфильтративного эндометриоза ректовагинальной перегородки
GB2594726A (en) * 2020-05-05 2021-11-10 Nadezhda Reproductive Science Ood Adenomyosis associated infertility and HDACIs

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US389A (en) 1837-09-21 Mode of supporting the bodies of railroad-cars and carriages
US720A (en) 1838-04-28 Improved mode of forming a kiln for making charcoal
US4038A (en) 1845-05-10 Boot-crimp
US5362A (en) 1847-11-06 Ice-ctjttee
US5543A (en) 1848-05-02 of jbesey city
US61303A (en) * 1867-01-15 James yocom
US150A (en) 1837-03-25 Island
US12703A (en) * 1855-04-10 Gabhst-chaie
US3089815A (en) * 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
FR2663223B1 (fr) 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
GB2252497B (en) 1991-02-04 1995-01-18 Elsimar Metzker Coutinho Pharmaceutical composition
JPH0735335B2 (ja) 1991-02-28 1995-04-19 五十嵐 正雄 子宮内膜症の治療薬
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
RU2073534C1 (ru) 1993-06-04 1997-02-20 Сочинский научно-исследовательский институт курортологии и физиотерапии МЗ РФ Способ лечения генитального эндометриоза
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
DK0792152T3 (da) * 1994-11-22 2004-07-12 Balance Pharmaceuticals Inc Fremgangsmåder til svangerskabsforebyggelse
EP0785212A1 (en) 1996-01-22 1997-07-23 Laboratoire Theramex New 19-nor-pregnene derivatives
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
JP2002525268A (ja) * 1998-09-16 2002-08-13 オンコファーマシューティカル， インコーポレイテッド ゴルジ装置妨害剤の注射可能な処方物での腫瘍学的腫瘍の処置
JP2002527380A (ja) * 1998-10-09 2002-08-27 ファルマシア・アンド・アップジョン・カンパニー 閉経および子宮内膜症の治療用の皮下酢酸メドロキシプロゲステロン
JP2001051773A (ja) * 1999-08-16 2001-02-23 Toshiaki Matsuhashi キーボードカバー
US6613355B2 (en) * 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
JP2003533464A (ja) * 2000-05-15 2003-11-11 フアルマシア・イタリア・エツセ・ピー・アー 安定化ステロイド懸濁液
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
WO2002028387A1 (en) 2000-10-03 2002-04-11 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
US20020072509A1 (en) * 2000-10-11 2002-06-13 Stein Donald Gerald Methods for the treatment of a traumatic central nervous system injury
AU2002242231B2 (en) * 2001-02-23 2007-09-06 Genentech, Inc. Erodible polymers for injection
JP4273208B2 (ja) * 2001-03-30 2009-06-03 チッソ株式会社 婦人科疾患治療剤
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms

Also Published As

Publication number Publication date
CA2537702A1 (en) 2005-03-10
DK1660009T3 (en) 2015-04-27
WO2005020880A3 (en) 2006-05-26
BRPI0413200A (pt) 2006-10-03
AU2004267956A1 (en) 2005-03-10
HUE025239T2 (en) 2016-03-29
JP2013035866A (ja) 2013-02-21
US9532995B2 (en) 2017-01-03
US20050085453A1 (en) 2005-04-21
MA28083A1 (fr) 2006-08-01
WO2005020880A2 (en) 2005-03-10
JP2007509032A (ja) 2007-04-12
HK1095529A1 (en) 2007-05-11
EA015356B1 (ru) 2011-06-30
KR20070017946A (ko) 2007-02-13
TNSN06070A1 (en) 2007-10-03
EA200600524A1 (ru) 2006-08-25
JP5651279B2 (ja) 2015-01-07
EP1660009A2 (en) 2006-05-31
EP2617411A1 (en) 2013-07-24
CA2537702C (en) 2012-01-03
EP1660009A4 (en) 2010-02-17
PL1660009T3 (pl) 2015-08-31
IL174014A0 (en) 2006-08-01
EP1660009B1 (en) 2015-01-28
PT1660009E (pt) 2015-05-18
AU2004267956B2 (en) 2010-09-16
KR101288265B1 (ko) 2013-07-26
KR101285137B1 (ko) 2013-07-11
HRP20150440T1 (hr) 2015-07-03
CN101849906A (zh) 2010-10-06
US9468647B2 (en) 2016-10-18
SI1660009T1 (sl) 2015-07-31
ES2535430T3 (es) 2015-05-11
KR20120005062A (ko) 2012-01-13
US20150044291A1 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
NO20061502L (no) Fremgangsmate for behandling av endometriose
NO20062508L (no) Administrering av levodopa og karbidopa
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20083523L (no) Sammensetning for vaginal anvendelse
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
ATE464889T1 (de) Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
WO2005089411A3 (en) Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NO20062699L (no) Smelteblandingsdispergeringer
NO20035732L (no) Diagnostiske analyser for parvovirus B19
ATE473728T1 (de) Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare
IL164212A0 (en) Thiazolidine carboxamide derivatives, their preparation and pharmaceutical compositions containing them
NO20082098L (no) Formuleringer av AICA-ribosid
NO20072854L (no) Acylerte nonadepsipeptider anvendt som lysobaktinderivater
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
NO20040611L (no) Ekspanderbar gastrisk retensjonsanordning.
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
NO20085412L (no) Pyrrolidinderivater som har aktivitet ved GLYT1 transportoren
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application